Moderna Says Trial Suggests Redesigned Vaccines Protect Against Variants
Researchers combined Moderna’s existing vaccine with one designed to attack the Beta variant, and found it provided a stronger defense against several variants.
View original article
Contributor: Sharon LaFraniere
